Ubiquitin-mediated interaction of p210 BCR/ABL with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia.
about
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemiaRegulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche.Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2.
P2860
Ubiquitin-mediated interaction of p210 BCR/ABL with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ubiquitin-mediated interaction ...... chronic myelogenous leukemia.
@en
Ubiquitin-mediated interaction ...... chronic myelogenous leukemia.
@nl
type
label
Ubiquitin-mediated interaction ...... chronic myelogenous leukemia.
@en
Ubiquitin-mediated interaction ...... chronic myelogenous leukemia.
@nl
prefLabel
Ubiquitin-mediated interaction ...... chronic myelogenous leukemia.
@en
Ubiquitin-mediated interaction ...... chronic myelogenous leukemia.
@nl
P2093
P2860
P1433
P1476
Ubiquitin-mediated interaction ...... chronic myelogenous leukemia.
@en
P2093
Gwendolyn M Mahon
Harvey L Ozer
Ian P Whitehead
Ilona Tala
Nicole L Pannucci
Tinghui Hu
P2860
P304
P356
10.1182/BLOOD-2013-01-481184
P407
P577
2013-08-15T00:00:00Z